ReviewBioImpacts : BI2026

Checkpoint inhibition and beyond: Precision immune engineering for the immune-privileged landscape of ocular malignancies.

Qamar Abuhassan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.